SPDR S&P Biotech (XBI)

Add to Watchlists
Create an Alert
180.51 +2.81  +1.58% NYSE Arca Nov 26, 8:00PM BATS Real time Currency in USD
View Full Chart
XBI Price Chart

XBI Description

SPDR S&P Biotech is a long only equity fund managed by SPDR State Street Global Advisors that tracks the S&P Biotechnology Select Industry TR USD index and has 1.345B USD assets under management. It has an expected distribution yield of 0.86%, a Forecasted PE Ratio of 43.52, and a Forecasted Price to Book Value of 4.636. The fund has a net expense ratio of 0.35%, turns over its positions 86.00% per year, and is traded on the New York Stock Exchange Arca.

XBI Key Info

Expense Ratio (10-31-14) 0.35%
Assets Under Management (11-26-14) 1.345B
30-Day Average Volume (11-26-14) 402078.1
Net Asset Value (11-26-14) 180.53
Discount or Premium to NAV (11-26-14) -0.01%
Turnover Ratio (6-30-14) 86.00%

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.11% 0.11% 0.00%
Stock 99.89% 99.89% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Nov. 25, 2014

XBI Region Exposure

Americas 97.48%
North America 97.48%
Latin America 0.00%
Greater Europe 2.52%
United Kingdom 0.00%
Europe Developed 2.52%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Nov. 24, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Nov. 25, 2014

XBI Stock Market Capitalization

Giant 4.97%
Large 4.16%
Medium 16.82%
Small 32.62%
Micro 41.33%
As of Nov. 25, 2014
View More Holdings

XBI Top 10 Holdings

Name % Weight Price Chg %
Agios Pharmaceuticals Inc 2.56% 102.44 +4.50%
Receptos Inc 2.40% 129.47 +4.24%
Incyte Corp Ltd 1.73% 75.01 +2.56%
Geron Corp 1.68% 3.72 +3.62%
AMAG Pharmaceuticals Inc 1.66% 37.16 +0.98%
PTC Therapeutics Inc 1.57% 44.82 +0.47%
Celldex Therapeutics Inc 1.55% 20.54 +0.79%
Alnylam Pharmaceuticals Inc 1.54% 100.73 +3.62%
Anacor Pharmaceuticals Inc 1.54% 35.06 +5.92%
Biomarin Pharmaceutical Inc 1.52% 89.38 -0.08%
As of Nov. 25, 2014
Get Quote for
Advertisement

XBI Basic Info

Style
Asset Class Sector Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD 100.0%
Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2014
Last Prospectus Date 10/31/2014
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available RRSP No

XBI Manager Info

Name Tenure
John Tucker 8.75 yrs
Karl Schneider 0.00 yrs
Michael Feehily 3.00 yrs

XBI Risk Info

Beta 1.125
30 Day Average Volatility 25.40%

XBI Fundamentals

Dividend Yield TTM (11-26-14) 0.86%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 13.76
Weighted Average Price to Book Ratio 6.636
Weighted Median ROE -18.69%
Weighted Median ROA -22.41%
Forecasted Dividend Yield 0.03%
Forecasted PE Ratio 43.52
Forecasted Price to Sales Ratio 10.54
Forecasted Price to Book Ratio 4.636
Number of Holdings 82.00
As of Nov. 25, 2014

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 19.47%
Forecasted Book Value Growth 8.00%
Forecasted Cash Flow Growth 23.90%
Forecasted Earnings Growth 22.52%
Forecasted Revenue Growth -2.18%
As of Nov. 25, 2014

XBI Performance

  Returns Total Returns
1M 7.94% 7.94%
3M 10.82% 11.21%
6M 40.18% 41.24%
1Y 40.43% 41.83%
3Y 202.0% 206.1%
5Y 255.5% 260.5%
As of Nov. 26, 2014

XBI Flows

1M 16.93M
3M 50.73M
6M 8.961M
YTD 81.45M
1Y 33.36M
3Y 215.13M
5Y 130.23M
As of Oct. 31, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.